Effects of estradiol and the angiotensin II receptor blocker irbesartan on vascular function in postmenopausal women

Abstract

The results suggest that irbesartan and estradiol, when used in combination, may cause a greater lowering of blood pressure in postmenopausal hypertensive women. This effect may be mediated via increased vasodilation and lower aldosterone levels. These results warrant further testing in larger clinical trials.